Literature DB >> 9843040

Population-based study of congenital heart defects in Down syndrome.

S B Freeman1, L F Taft, K J Dooley, K Allran, S L Sherman, T J Hassold, M J Khoury, D M Saker.   

Abstract

Mental retardation and hypotonia are found in virtually all Down syndrome (DS) individuals, whereas congenital heart defects (CHDs) are only present in a subset of cases. Although there have been numerous reports of the frequency of CHDs in DS, few of the studies have had complete ascertainment of DS in a defined geographic area. The Atlanta Down Syndrome Project, a population-based study of infants born with trisomy 21, provides such a resource. In the first 6.5 years of the study, 243 trisomy 21 livebirths were identified in the five-county Atlanta area (birth prevalence: 9.6/10,000). Cardiac diagnoses were available on 227 (93%) of the cases and 89% of these evaluations were made by echocardiography, cardiac catheterization, surgery, or autopsy. Of the 227 DS infants, 44% had CHDs including 45% atrioventricular septal defect (with or without other CHDs), 35% ventricular septal defect (with or without other CHDs), 8% isolated secundum atrial septal defect, 7%, isolated persistent patent ductus arteriosus, 4% isolated tetralogy of Fallot, and 1% other. This report is unique in that it contains the largest number of trisomy 21 infants ascertained in a population-based study where modern techniques for diagnosing cardiac abnormalities predominate.

Entities:  

Mesh:

Year:  1998        PMID: 9843040

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  90 in total

1.  Neurodevelopmental outcomes in children with Down syndrome and congenital heart defects.

Authors:  Jeannie Visootsak; William T Mahle; Paul M Kirshbom; Lillie Huddleston; Marcia Caron-Besch; Amy Ransom; Stephanie L Sherman
Journal:  Am J Med Genet A       Date:  2011-09-19       Impact factor: 2.802

Review 2.  Heart valve development: endothelial cell signaling and differentiation.

Authors:  Ehrin J Armstrong; Joyce Bischoff
Journal:  Circ Res       Date:  2004-09-03       Impact factor: 17.367

3.  Intravenous thrombolysis for ischaemic stroke in Down syndrome.

Authors:  Simone Gallerini; Alberto Chiti; Gino Gialdini; Nicola Giannini; Giovanni Orlandi
Journal:  Neurol Sci       Date:  2011-12-31       Impact factor: 3.307

4.  Looking down the atrioventricular canal.

Authors:  D Woodrow Benson; Kristen Lipscomb Sund
Journal:  Cardiovasc Res       Date:  2010-09-20       Impact factor: 10.787

5.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

Review 6.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

7.  Screening key genes associated with congenital heart defects in Down syndrome based on differential expression network.

Authors:  Shan Yu; Huani Yi; Zhimin Wang; Juan Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 8.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

9.  Prevalence of Obstructive Sleep Apnea in Children With Down Syndrome: A Meta-Analysis.

Authors:  Chia-Fan Lee; Chia-Hsuan Lee; Wan-Yi Hsueh; Ming-Tzer Lin; Kun-Tai Kang
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

10.  Down Syndrome - Genetics and Cardiogenetics.

Authors:  Vasilica Plaiasu
Journal:  Maedica (Bucur)       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.